REBECCA WESTENDORFF: Open Payments
NPI 1376647081 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $239 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Amgen Inc. | 3 | $109 |
| Novo Nordisk Inc | 3 | $92 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| PFIZER INC. | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
Products named: LEQVIO, Wegovy, REPATHA, VERQUVO, Kerendia, JARDIANCE, ELIQUIS, LUX-Dx Insertable Cardiac Monitor.
Industry payments across NC — which companies pay providers there.
